Literature DB >> 12110673

A functionally active human F1F0 ATPase can be purified by immunocapture from heart tissue and fibroblast cell lines. Subunit structure and activity studies.

Robert Aggeler1, Juliana Coons, Steven W Taylor, Soumitra S Ghosh, José J Garcia, Roderick A Capaldi, Michael F Marusich.   

Abstract

Human mitochondrial F(1)F(0) ATP synthase was isolated with a one-step immunological approach, using a monoclonal antibody against F(1) in a 96-well microplate activity assay system, to establish a method for fast high throughput screening of inhibitors, toxins, and drugs with very small amounts of enzyme. For preparative purification, mitochondria from human heart tissue as well as cultured fibroblasts were solubilized with dodecyl-beta-d-maltoside, and the F(1)F(0) was isolated with anti-F(1) monoclonal antibody coupled to protein G-agarose beads. The immunoprecipitated F(1)F(0) contained a full complement of subunits that were identified with specific antibodies against five of the subunits (alpha, beta, OSCP, d, and IF(1)) and by MALDI-TOF and/or LC/MS/MS for all subunits except subunit c, which could not be resolved by these methods because of the limits of detection. Microscale immunocapture of F(1)F(0) from detergent-solubilized mitochondria or whole cell fibroblast extracts was performed using anti-F(1) monoclonal antibody immobilized on 96-well microplates. The captured complex V displayed ATP hydrolysis activity that was fully oligomycin and inhibitor protein IF(1)-sensitive. Moreover, IF(1) could be co-isolated with F(1)F(0) when the immunocapture procedure was carried out at pH 6.5 but was absent when the ATP synthase was isolated at pH 8.0. Immunocaptured F(1)F(0) lacking IF(1) could be inhibited by more than 90% by addition of recombinant inhibitor protein, and conversely, F(1)F(0) containing IF(1) could be activated more than 10-fold by brief exposure to pH 8.0, inducing the release of inhibitor protein. With this microplate system an ATP hydrolysis assay of complex V could be carried out with as little as 10 ng of heart mitochondria/well and as few as 3 x 10(4) cells/well from fibroblast cultures. The system is therefore suitable to screen patient-derived samples for alterations in amount or functionality of both the F(1)F(0) ATPase and IF(1).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12110673     DOI: 10.1074/jbc.M204538200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Assessing actual contribution of IF1, inhibitor of mitochondrial FoF1, to ATP homeostasis, cell growth, mitochondrial morphology, and cell viability.

Authors:  Makoto Fujikawa; Hiromi Imamura; Junji Nakamura; Masasuke Yoshida
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

2.  An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity of angiostatin on the endothelial cell surface.

Authors:  Nick R Burwick; Miriam L Wahl; Jun Fang; Zhaoxi Zhong; Tammy L Moser; Bo Li; Roderick A Capaldi; Daniel J Kenan; Salvatore V Pizzo
Journal:  J Biol Chem       Date:  2004-11-04       Impact factor: 5.157

3.  Genome sequence of a novel deep-sea vent epsilonproteobacterial phage provides new insight into the co-evolution of Epsilonproteobacteria and their phages.

Authors:  Yukari Yoshida-Takashima; Yoshihiro Takaki; Shigeru Shimamura; Takuro Nunoura; Ken Takai
Journal:  Extremophiles       Date:  2013-03-20       Impact factor: 2.395

4.  Cross-linking of the endogenous inhibitor protein (IF1) with rotor (gamma, epsilon) and stator (alpha) subunits of the mitochondrial ATP synthase.

Authors:  Fernando Minauro-Sanmiguel; Concepción Bravo; José J García
Journal:  J Bioenerg Biomembr       Date:  2002-12       Impact factor: 2.945

5.  ATP synthases: cellular nanomotors characterized by LILBID mass spectrometry.

Authors:  Jan Hoffmann; Lucie Sokolova; Laura Preiss; David B Hicks; Terry A Krulwich; Nina Morgner; Ilka Wittig; Hermann Schägger; Thomas Meier; Bernd Brutschy
Journal:  Phys Chem Chem Phys       Date:  2010-08-27       Impact factor: 3.676

6.  Overexpression of the inhibitor protein IF(1) in AS-30D hepatoma produces a higher association with mitochondrial F(1)F(0) ATP synthase compared to normal rat liver: functional and cross-linking studies.

Authors:  Concepción Bravo; Fernando Minauro-Sanmiguel; Edgar Morales-Ríos; José S Rodríguez-Zavala; José J García
Journal:  J Bioenerg Biomembr       Date:  2004-06       Impact factor: 2.945

7.  IEX-1 targets mitochondrial F1Fo-ATPase inhibitor for degradation.

Authors:  L Shen; L Zhi; W Hu; M X Wu
Journal:  Cell Death Differ       Date:  2008-12-19       Impact factor: 15.828

8.  Inhibition of the ecto-beta subunit of F1F0-ATPase inhibits proliferation and induces apoptosis in acute myeloid leukemia cell lines.

Authors:  Zhao Wen-Li; Wang Jian; Tao Yan-Fang; Feng Xing; Li Yan-Hong; Zhu Xue-Ming; Zhang Min; Ni Jian; Pan Jian
Journal:  J Exp Clin Cancer Res       Date:  2012-11-09

9.  IF1, a natural inhibitor of mitochondrial ATP synthase, is not essential for the normal growth and breeding of mice.

Authors:  Junji Nakamura; Makoto Fujikawa; Masasuke Yoshida
Journal:  Biosci Rep       Date:  2013-09-17       Impact factor: 3.840

10.  Predicting the targeting of tail-anchored proteins to subcellular compartments in mammalian cells.

Authors:  Joseph L Costello; Inês G Castro; Fátima Camões; Tina A Schrader; Doug McNeall; Jing Yang; Evdokia-Anastasia Giannopoulou; Sílvia Gomes; Vivian Pogenberg; Nina A Bonekamp; Daniela Ribeiro; Matthias Wilmanns; Gregory Jedd; Markus Islinger; Michael Schrader
Journal:  J Cell Sci       Date:  2017-03-21       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.